IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,202,067 | +116.4% | 78,042 | +88.5% | 0.01% | +100.0% |
| Q1 2023 | $1,479,779 | +26.4% | 41,406 | +33.6% | 0.00% | +33.3% |
| Q4 2022 | $1,170,870 | -93.6% | 31,000 | -94.8% | 0.00% | -88.5% |
| Q4 2021 | $18,315,000 | +4334.6% | 601,883 | +4787.4% | 0.03% | +2500.0% |
| Q3 2021 | $413,000 | -23.5% | 12,315 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $540,000 | -83.7% | 13,535 | -82.0% | 0.00% | -94.1% |
| Q1 2018 | $3,306,000 | +94.5% | 75,000 | +121.9% | 0.02% | +112.5% |
| Q4 2017 | $1,700,000 | -20.2% | 33,799 | -19.5% | 0.01% | -33.3% |
| Q3 2017 | $2,129,000 | +39.5% | 42,000 | +40.0% | 0.01% | +50.0% |
| Q2 2017 | $1,526,000 | -89.4% | 30,000 | -90.0% | 0.01% | -89.2% |
| Q4 2016 | $14,349,000 | – | 300,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |